Combination of a strategy to prolong dendritic cell survival and a strategy to bypass antigen processing enhances DNA vaccine potency.

被引:0
|
作者
Huang, BK [1 ]
Peng, SW [1 ]
Huang, CH [1 ]
He, LM [1 ]
Hung, CF [1 ]
Wu, TC [1 ]
机构
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2747S / 2747S
页数:1
相关论文
共 23 条
  • [21] M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine
    Ye, Ting
    Yue, Yan
    Fan, Xiangmei
    Dong, Chunsheng
    Xu, Wei
    Xiong, Sidong
    VACCINE, 2014, 32 (35) : 4457 - 4465
  • [22] A DNA-Modified Live Vaccine Prime-Boost Strategy Broadens the T-Cell Response and Enhances the Antibody Response against the Porcine Reproductive and Respiratory Syndrome Virus
    Bernelin-Cottet, Cindy
    Urien, Celine
    Stubsrud, Elisabeth
    Jakob, Virginie
    Bouguyon, Edwige
    Bordet, Elise
    Barc, Celine
    Boulesteix, Olivier
    Contreras, Vanessa
    Barnier-Quer, Christophe
    Collin, Nicolas
    Trus, Ivan
    Nauwynck, Hans
    Bertho, Nicolas
    Schwartz-Cornil, Isabelle
    VIRUSES-BASEL, 2019, 11 (06):
  • [23] DNA vaccines employing intracellular targeting strategies and a strategy to prolong dendritic cell life generate a higher number of CD8+ memory T cells and better long-term antitumor effects compared with a DNA prime-vaccinia boost regimen
    Kim, TW
    Lee, JH
    He, LM
    Boyd, DAK
    Hung, CF
    Wu, TC
    HUMAN GENE THERAPY, 2005, 16 (01) : 26 - 34